SONM
DNA X, Inc.NASDAQTechnology$3.63+2.98%ClosedMarket Cap: $3.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-49.18
P/S
0.06
EV/EBITDA
-0.23
DCF Value
$-34.65
FCF Yield
-723.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.3%
Operating Margin
-54.4%
Net Margin
-56.5%
ROE
1515.0%
ROA
-83.0%
ROIC
-520.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $16.2M | 11.2% | $-4.0M | $-4.8M | $-4.83 | — |
| Q2 2025 | $11.2M | 7.6% | $-6.7M | $-7.5M | $-0.79 | — |
| Q1 2025 | $16.7M | 50.0% | $645.0K | $458.0K | $0.08 | — |
| Q4 2024 | $15.0M | -1.2% | $-22.1M | $-21.6M | $-4.42 | — |
| FY 2024 | $58.3M | 17.0% | $-33.6M | $-33.6M | $-7.13 | — |
| Q3 2024 | $15.0M | 28.2% | $-2.4M | $-2.5M | $-0.52 | — |
| Q2 2024 | $11.5M | 25.8% | $-6.5M | $-6.6M | $-1.41 | — |
| Q1 2024 | $16.8M | 17.3% | $-2.7M | $-2.9M | $-0.65 | — |
| Q4 2023 | $13.4M | 38.1% | $-1.3M | $-1.4M | $-0.31 | — |
| FY 2023 | $93.6M | 20.6% | $513.0K | $-90.0K | $-0.02 | — |
| Q3 2023 | $27.6M | 20.3% | $688.0K | $527.0K | $0.12 | — |
| Q2 2023 | $26.8M | 16.5% | $747.0K | $509.0K | $0.11 | — |